Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine versus EMLA cream versus lidocaine jelly for catheter-related bladder discomfort
IRCT20210228050530N1Phase 3Completed
- Sponsor
- Gonabad University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in cystitis comparing Hyoscine N-butyl bromide, EMLA cream and Lidocaine jelly control (3 arms). Primary endpoint: Incidence of catheter-related bladder discomfort. Started Apr 2021; status: completed.
02
Drugs
hyoscine butylbromidelidocaine + prilocainelidocaine
03
Conditions
cystitis
Beyond the preview
Go deeper on IRCT20210228050530N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210228050530N1.